OR WAIT null SECS
Jill Murphy is Editor of Pharmaceutical Technology.
May 25, 2023
This agreement is intended to be executed and see the impact of any financial transfers by the fiscal year ending March 31, 2024.
In this episode of Drug Digest, Pharmaceutical Technology editors discuss what happens in early phase development, the role of CDMOs, and highlight the benefits and challenges of the outsourcing process.
May 24, 2023
The new CGMP facility is expected to contribute to the development of mRNA therapeutics, with a building designed for the CGMP manufacture of mRNA-based in-vivo gene editing, gene-edited cell therapies, protein replacement therapies, cancer vaccines, and infectious disease vaccines.
The facility is based on a state-of-the-art design concept that allows maximum flexibility for a multi-product, multi-platform offering.
May 18, 2023
The new partnership hopes to increase funding and awareness of global health security challenges and highlight the role of the pharmaceutical industry in increasing access to medicines and improving health worldwide.
May 17, 2023
The new method was developed to isolate tissue-specific EVs from the blood in addition to using a workflow to analyze their diverse multi-omics content.